Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs

Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs

US Patent 8343493 · Granted Jan 1, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti Tau SVQIVYKPV epitope single domain antibody2025
Treatment of myotonic dystrophy2025
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
Treatment of myotonic dystrophy2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Humanized antibodies specific to the protofibrillar form of the beta-amyloid pep2018
1,4-bis(3-aminopropyl)piperazine derivative and its use2018
1,4-bis(3-aminopropyl)piperazine derivative and its use2018